Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 50 and 90 years old
- You are male or female
- You have been diagnosed with mild cognitive impairment (MCI) or mild Alzheimer's disease
- Your memory and thinking test scores fall within a specific range showing mild impairment (confirm with trial site)
- A special brain scan or spinal fluid test has confirmed the presence of amyloid protein associated with Alzheimer's disease
- You have a trusted caregiver who can accompany you to appointments and help you take the study medication correctly
- You are willing to participate and sign a consent form agreeing to take part
Who may not be able to join:
- Your memory or thinking problems are caused by something other than Alzheimer's disease
- You have had a mini-stroke, stroke, brain bleed, or seizure in the past 12 months
- You have significant signs of depression, any suicidal behaviour in the past 6 months, or symptoms such as hallucinations, severe anxiety, or paranoia
- You have a bleeding disorder, are taking blood-thinning medication, or have serious diseases affecting the gut, kidneys, liver, lungs, immune system, hormones, or heart
- You have had an allergic reaction to the study drug (ranucimab) or any similar antibody-based treatment
- You cannot have an MRI scan, for example because you have a pacemaker or certain metal implants in your body
- You have had problems with drug or alcohol misuse within the past 2 years
- You have taken part in another Alzheimer's clinical trial using a similar type of drug within the past 6 months (unless you can confirm you received only a placebo)
- You are planning to have surgery under general anaesthesia during the trial
- You are pregnant, breastfeeding, or have a positive pregnancy test at the start of the trial (for female participants)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cui bai Wei, Xuan Wu Hospital of Capital Medical University
Phone: 83198319
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Resting-state fMRI brain network metrics (Independent Component Analysis)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.